Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MonaLisa is a specialized medical device company based in Belgium that focuses on women's reproductive health through the development and manufacture of intrauterine devices (IUDs). The company offers a comprehensive portfolio of copper-based contraceptive solutions, including various shapes and sizes such as the Mona Lisa Cu375 and CuT 380A, designed to accommodate different anatomical needs. Its products provide long-term, hormone-free birth control and are distributed in numerous international markets. In May 2023, MonaLisa was acquired by Exeltis, the women's health division of the global pharmaceutical group Insud Pharma. This acquisition integrated MonaLisa's established product line into a broader global reproductive health strategy.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Mona Lisa.